Patent holdings for IPC class A61K 31/713

Total number of patents in this class: 7725

10-year publication summary

549
478
561
527
493
506
678
550
559
476
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1138
394
Arrowhead Pharmaceuticals, Inc.
317
126
The Regents of the University of California
20211
96
University of Massachusetts
2255
95
Nitto Denko Corporation
8350
78
Ionis Pharmaceuticals, Inc.
896
76
Inserm (institut National de La Sante et de La Recherche Medicale)
3370
69
Dicerna Pharmaceuticals, Inc.
200
63
Regeneron Pharmaceuticals, Inc.
4394
56
Centre National de La Recherche Scientifique
10641
49
The General Hospital Corporation
4794
47
Immunomedics, Inc.
260
44
Arbutus Biopharma Corporation
177
43
Novartis AG
10674
40
The Johns Hopkins University
5737
40
Suzhou Ribo Life Science Co., Ltd.
122
40
Institut National de La Sante et de La Recherche Medicale (inserm)
2953
37
Northwestern University
3440
35
Sirnaomics, Inc.
114
35
Avidity Biosciences, Inc.
176
35
Other owners 6227